3.85
Gain Therapeutics Inc (GANX) 最新ニュース
Gain Therapeutics, Inc. (GANX) 5.14% in After-hours: What’s Driving the Move? - Stocks Telegraph
FY2025 Earnings Forecast for GANX Issued By HC Wainwright - MarketBeat
HC Wainwright Predicts Higher Earnings for Gain Therapeutics - Defense World
H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data By Investing.com - Investing.com South Africa
Gain Therapeutics Inc (GANX) expanding its growth trajectory ahead - Setenews
H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data - Investing.com India
Gain Therapeutics’ (GANX) Preclinical Momentum Drives Its Progress in Parkinson’s Drug Development - MSN
What drives Gain Therapeutics Inc stock priceGrowth vs. Value Investing & Low Cost Market Strategies - earlytimes.in
Gain Therapeutics files prospectus supplement for $35.5 million stock offering By Investing.com - Investing.com Australia
Gain Therapeutics' (GANX) Preclinical Momentum Drives Its Progress in Parkinson's Drug Development - Finviz
Gain Therapeutics Announces New Stock Offering Program - TipRanks
Gain Therapeutics files prospectus supplement for $35.5 million stock offering - Investing.com
Gain Therapeutics files prospectus for $35.5 million stock saleSEC filing - marketscreener.com
Gain Therapeutics Files Prospectus Supplement for Stock Offering - TradingView
Can Gain Therapeutics Inc. stock sustain institutional interestTrend Reversal & Smart Allocation Stock Reports - BỘ NỘI VỤ
12 Hot Penny Stocks to Invest in Right Now - Insider Monkey
Valuation Update: Why Gain Therapeutics Inc. stock could see breakout soonNew Guidance & Daily Technical Stock Forecast Reports - moha.gov.vn
A History of Outperforming Analyst Forecasts and Beating the Odds: Gain Therapeutics Inc (GANX) - Setenews
Gain Therapeutics Inc Stock Analysis and ForecastRisk-Reward Ratio Analysis & Rapid Wealth Building Tips - earlytimes.in
How Gain Therapeutics Inc. stock compares to industry benchmarksWeekly Profit Report & Expert Approved Trade Ideas - newser.com
Gain Therapeutics presents data on GT-02287 - TipRanks
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025 - The Manila Times
Gain Therapeutics (Nasdaq: GANX) Reports GT-02287 Mitochondrial, Neuronal Data - Stock Titan
Will Gain Therapeutics Inc. stock deliver strong dividend growthInsider Buying & Real-Time Volume Analysis Alerts - newser.com
Gain Therapeutics Inc. stock outlook for YEARJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com
Is Gain Therapeutics Inc. stock ready for a breakoutWeekly Trade Recap & Weekly Breakout Watchlists - newser.com
Can machine learning forecast Gain Therapeutics Inc. recovery2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know - sharewise.com
How does Gain Therapeutics Inc (GANX) change from a tortoise to a hare? - Setenews
Is Gain Therapeutics Inc. stock undervalued vs historical averagesQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Equities Analysts Set Expectations for GANX FY2025 Earnings - Defense World
Will Gain Therapeutics Inc. stock go up soon2025 Price Targets & AI Enhanced Trading Signals - newser.com
Can Gain Therapeutics Inc. stock deliver sustainable ROEWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com
Why Gain Therapeutics Inc. stock remains on buy listsJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Is Gain Therapeutics Inc. stock a buy before product launchesMarket Trend Review & Safe Capital Preservation Plans - newser.com
Building trade automation scripts for Gain Therapeutics Inc.Weekly Trading Summary & Verified Momentum Watchlists - newser.com
大文字化:
|
ボリューム (24 時間):